Download PDF
Thromb Haemost 1996; 76(04): 577-584
DOI: 10.1055/s-0038-1650625
Original Article
Schattauer GmbH Stuttgart

Characterization of Cellular Binding Sites and Interactive Regions within Reactants Required for Enhancement of Plasminogen Activation by tPA on the Surface of Leukocytic Cells[*]

Jordi Félez
1   Institut Recerca Oncologica (IRO), Hospital Duran i Reynals, Barcelona, Spain
,
Lindsey A Miles
2   Department of Vascular Biology, The Scripps Research Institute, La Jolla, CA, USA
,
Pere Fabregas
1   Institut Recerca Oncologica (IRO), Hospital Duran i Reynals, Barcelona, Spain
,
Merce Jardi
1   Institut Recerca Oncologica (IRO), Hospital Duran i Reynals, Barcelona, Spain
,
Edward F Plow
3   Joseph J. Jacobs Center for Thrombosis and Vascular Biology, The Cleveland Clinic Foundation, Cleveland, OH, USA
,
Roger H Lijnen
4   Center for Molecular and Vascular Biology, University of Leuven, Belgium
› Author Affiliations
Further Information

Publication History

Received: 08 May 1996

Accepted after revision25 June 1996

Publication Date:
10 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Plasminogen and tPA bind to a common set of binding sites on nucleated cells. To assess the functional consequences of cellular binding, we have measured the kinetic changes induced by plasminogen activation by tPA on cell surfaces. These studies were carried out with U937 and THP-1 monocytoid cells, with Raji, Nalm6 and Molt4 lymphoid cells and with peripheral blood monocytes and neutrophils. The interactions of plasminogen and tPA with cells induced an increase in the rate of plasmin generation which depended upon the cell concentration. With saturating amounts of U937 monocytoid cells (1.25 × 105/ml) the rate of plasmin generation was 0.39 nM.s-1 versus 0.07 and 0.09 nM.s-1 without cells or without tPA, respectively. The catalytic efficiency of Glu- or Lys-plasminogen activation by tPA increased by 7.2- and 24.2-fold, respectively. These changes were induced by a 72-242-fold reduction in the Km of these interactions which was in the range of 0.3-0.9 µM. These values are below the plasminogen concentration in plasma (1-2 µM). Moreover, we provide new data indicating that 1) only a specific subset of plasminogen binding sites, i.e. molecules exposing carboxyl terminal lysines on the cell surface, promotes plasminogen activation on cells; 2) the first four kringles of plasminogen and the finger of tPA are critical for enhanced plasmin generation on cell surfaces; 3) the simultaneous co-localization of tPA with plasminogen on cell surfaces is required for enhanced plasminogen activation; 4) modulation of plasminogen/tPA receptor expression induces concomitant modulation of the stimulatory effects of cells on plasminogen activation and 5) in a direct comparison, the mechanism by which cells and fibrin fragments accelerate plasminogen activation are similar but not identical. These data suggest that modulation of plasminogen/tPA binding sites permits local and efficient generation of plasmin on cell surfaces.

This work was supported by DGICYT PM92-0178, FIS 93/5235 (J.F.); FIS 93/0331 (M.J.); NFWO grant G.0126.96 (R.H.L.) and NIH grants HL-45934, HL-38272 (L.A.M.), HL-17964 (E.F.P). This work was done during the tenure of an Established Investigatorship award from the American Heart Association and SmithKline Beechman to Dr.Miles.


 

  • References

  • 1 Plow EF, Felez J, Miles LA. Cellular Regulation of Fibrinolysis. Thromb Haemost 1991; 66: 32-36
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of Cell-Surface Lysines in Plasminogen Binding to Cells: Identification of alfa-Enolase as Candidate Plasminogen Receptor. Biochemistry 1991; 30: 1682-1691
    CrossrefPubMedGoogle Scholar
  • 3 Dudani AK, Pluskota A, Ganz PR. Interaction of tissue plasminogen activator with a human endothelial cell 45-kilodalton plasminogen receptor. Biochem Cell Biol 1994; 72: 126-131
    CrossrefPubMedGoogle Scholar
  • 4 Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 1994; 269: 21191-21197
    PubMedGoogle Scholar
  • 5 Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin mediated enhancement of t-PA dependent plasminogen activation. J Biol Chem 1994; 269: 21198-21203
    PubMedGoogle Scholar
  • 6 Lopez-Alemany R, Correc P, Camoin L, Burtin P. Purification of the plas-min receptor from human carcinoma cells and comparison to alpha-enolase. Thromb Res 1994; 75: 371-381
    CrossrefPubMedGoogle Scholar
  • 7 Parkkinen J, Rauvala H. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J Biol Chem 1991; 266: 16730-16735
    PubMedGoogle Scholar
  • 8 Kanalas JJ, Makker SP. Identification of the rat Heymann nephritis autoantigen (GP330) as a receptor site for plasminogen. J Biol Chem 1991; 266: 10825-10829
    PubMedGoogle Scholar
  • 9 Lottenberg R, Broder CC, Boyle MDP, Kain SJ, Schroeder BL, Curtiss R III. Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J Bacteriol 1992; 174: 5204-5210
    CrossrefPubMedGoogle Scholar
  • 10 Dudani AK, Cummings C, Hashemi S, Ganz PR. Isolation of a novel 45 kDa plasminogen receptor from human endothelial cells. Thromb Res 1993; 69: 185-196
    CrossrefPubMedGoogle Scholar
  • 11 Redlitz A, Fowler BJ, Plow EF, Miles LA. The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem 1995; 227: 407-415
    CrossrefPubMedGoogle Scholar
  • 12 Gonzalez-Gronow M, Gawdi G, Pizzo SV. Characterization of the plasminogen receptors of normal and rheumatoid arthritis human synovial fibroblasts. J Biol Chem 1994; 269: 4360-4366
    PubMedGoogle Scholar
  • 13 Miles LA, Dahlberg CM, Levin EG, Plow EF. Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells. Biochemistry 1989; 28: 9337-9343
    CrossrefPubMedGoogle Scholar
  • 14 Andrade-Gordon P, Strickland S. Interaction of heparin with plasminogen activators and plasminogen: Effects on the activation of plasminogen. Biochemistry 1986; 25: 4033-4040
    CrossrefPubMedGoogle Scholar
  • 15 Stack MS, Moser TL, Pizzo SV. Binding of human plasminogen to base-ment-membrane (type IV) collagen. Biochem J 1992; 284: 103-108
    CrossrefPubMedGoogle Scholar
  • 16 Stack S, Gonzalez-Gronow M, Pizzo SV. Regulation of plasminogen activation by components of the extracellular matrix. Biochemistry 1990; 29: 4966-4970
    CrossrefPubMedGoogle Scholar
  • 17 Camacho M, Fondaneche M, Burtin P. Limited proteolysis of tumor cells increase their plasmin-binding ability. FEBS Lett 1989; 245: 21-24
    CrossrefPubMedGoogle Scholar
  • 18 Felez J, Chanquia CJ, Fabregas P, Plow EF, Miles LA. Competition between Plasminogen and t-PA for Cellular Binding Sites. Blood 1993; 82: 2433-2441
    PubMedGoogle Scholar
  • 19 Blasi F, Conese M, Moller LB, Pedersen N, Cavallaro U, Cubellis MV. et al The Urokinase Receptor: Structure, Regulation and Inhibitor-mediated Internalization. Fibrinolysis 1994; 8: 182-188
    PubMedGoogle Scholar
  • 20 Vassalli J. The urokinase receptor. Fibrinolysis 1994; 8: 172-181
    PubMedGoogle Scholar
  • 21 Dano K, Behrendt N, Brunner N, Ellis V, Ploug M, Pyke C. The urokinase receptor: Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994; 8: 189-203
    PubMedGoogle Scholar
  • 22 Bu G, Warshawsky I, Schwartz AL. Cellular Receptors for the Plasminogen Activators. Blood 1994; 83: 3427-3436
    PubMedGoogle Scholar
  • 23 Felez J, Chanquia CJ, Levin EG, Miles LA, Plow EF. Binding of Tissue Plasminogen Activator to Human Monocytes and Monocytoid Cells. Blood 1991; 78: 2318-2327
    PubMedGoogle Scholar
  • 24 Felez J, Miles LA, Chanquia CJ, Hickey DM, Dahlberg CM, Plow EF. Competition of The Fibrinolytic Components, Plasminogen and Tissue Plasminogen Activator (t-PA), for Binding Sites on Monocytes and Monocytoid Cells. Thromb Haemost 1991; 65: 878 (A638)
    PubMedGoogle Scholar
  • 25 Hajjar KA. The endothelial cell tissue plasminogen activator receptor. Specific interaction with plasminogen. J Biol Chem 1991; 266: 21962-21970
    PubMedGoogle Scholar
  • 26 Dudani AK, Hashemi S, Aye MT, Ganz PR. Identification of an endothelial cell surface protein that binds plasminogen. Mol Cell Biochem 1991; 108: 133-140
    PubMedGoogle Scholar
  • 27 Vaughan DE, Mendelsohn ME, Declerc PJ, Van Houtte E, Collen D, Loscalzo J. Characterization of the binding of human tissue-type plasminogen activator to platelets. J Biol Chem 1989; 264: 15869-15874
    PubMedGoogle Scholar
  • 28 Romer J, Lund LR, Eriksen J, Pyke C, Kristensen P, Dano K. The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds. J Invest Dermatol 1994; 102: 519-522
    CrossrefPubMedGoogle Scholar
  • 29 Hajjar KA, Harpel PC, Jaffe EA, Nachman RL. Binding of plasminogen to cultured human endothelial cells. J Biol Chem 1986; 261: 11656-11662
    PubMedGoogle Scholar
  • 30 Felez J, Miles LA, Plescia J, Plow EF. Regulation of Plasminogen Receptor Expression on Human Monocytes and Monocytoid Cell Lines. J Cell Biol 1990; 111: 1673-1683
    CrossrefPubMedGoogle Scholar
  • 31 Gao S, Morser J, McLean K, Shuman MA. Differential effect of platelets on plasminogen activation by tissue plasminogen activator, urokinase and streptokinase. Thromb Res 1990; 58: 421-433
    CrossrefPubMedGoogle Scholar
  • 32 Miles LA, Plow EF. Binding and activation of plasminogen on the platelet surface. J Biol Chem 1985; 260: 4303-4311
    PubMedGoogle Scholar
  • 33 Plow EF, Freaney DE, Plescia J, Miles LA. The plasminogen system and cell surfaces: Evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol 1986; 103: 2411-2420
    CrossrefPubMedGoogle Scholar
  • 34 Ellis V, Scully MF, Kakkar VV. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. J Biol Chem 1989; 264: 2185-2188
    PubMedGoogle Scholar
  • 35 Ellis V, Behrendt N, Dano K. Plasminogen activation by receptor-bound urokinase: A kinetic study with both cell-associated and isolated receptor. J Biol Chem 1991; 266: 12752-12758
    PubMedGoogle Scholar
  • 36 Gonzalez-Gronow M, Stack S, Pizzo SV. Plasmin binding to the plasminogen receptor enhances catlytic efficiency and activates the receptor for subsequent ligand binding. Arc Biochem Biophys 1991; 286: 625-628
    CrossrefPubMedGoogle Scholar
  • 37 Hajjar KA, Hamel NM, Harpel PC, Nachman RL. Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin Invest 1987; 80: 1712-1719
    CrossrefPubMedGoogle Scholar
  • 38 Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. J Biol Chem 1982; 257: 2912-2919
    PubMedGoogle Scholar
  • 39 Lijnen HR, Van Hoef B, Collen D. On the molecular interactions between fibrin, tissue-type plasminogen activator and plasminogen. Thromb Res 1990; (Suppl. 57) Suppl 10: 45-54
    PubMedGoogle Scholar
  • 40 Dodd I, Mitchell DL, Entwisle C, Browne MJ, Robinson JH. Susceptibility of mutant, recombinant plasminogen activators to proteolytic breakdown: Removal of the F domain by plasmin. Fibrinolysis 1993; 7: 237-241
    PubMedGoogle Scholar
  • 41 Sturzebecher J, Newmann U, Kohnert U, Kresse GB, Fischer S. Mapping of the catalytic site of CHO-tPA and the y-PA variant BM 06.022 by synthetic inhibitors and substrates. Protein Science 1992; 1 (08) 100-113
    PubMedGoogle Scholar
  • 42 Deutsch DG, Mertz ET. Plasminogen: Purification from human plasma by affinity chromatography. Science 1970; 170: 1995-1996
    PubMedGoogle Scholar
  • 43 Miles LA, Plow EF. Topography of the high-affinity lysine binding site of plasminogen as defined with a specific antibody probe. Biochemistry 1986; 25: 6926-6933
    CrossrefPubMedGoogle Scholar
  • 44 Sottrup-Jensen L, Claeys H, Zajdel M, Petersen TE, Magnusson S. The primary structure of human plasminogen. In: Isolation of two lysine-binding fragments and one “mini-”plasminogen (MW 38,000) by elastase-cata-lyzed-specific limited proteolysis. Davidson JF, Rowan RM, Samama MM, Desnoyers PC, eds. Progress in Chemical Fibrinolysis and Thrombolysis, Vol. 3. New York: Raven Press 1978. 191-209
    PubMedGoogle Scholar
  • 45 Phillips DR, Morrison M. Exposed protein on the intact human erythrocyte. Biochemistry 1971; 10: 1766-1771
    CrossrefPubMedGoogle Scholar
  • 46 Zamarron C, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator. J Biol Chem 1984; 259 (04) 2080-2083
    PubMedGoogle Scholar
  • 47 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
    CrossrefPubMedGoogle Scholar
  • 48 Granelli-Pipemo A, Vassalli J, Reich E. Secretion of plasminogen activator by human polymorphonuclear leukocytes. J Exp Med 1989; 146: 1693-1705
    PubMedGoogle Scholar
  • 49 Miles LA, Ginsberg MH, White JG, Plow EF. Plasminogen interacts with human platelets through two distinct mechanisms. J Clin Invest 1986; 77: 2001-2009
    CrossrefPubMedGoogle Scholar
  • 50 Sehl LC, Castellino FJ. Thermodynamic properties of the binding of a-, omega-amino acids to the isolated kringle 4 region of human plasminogen as determined by high sensitivity titration calorimetry. J Biol Chem 1990; 265: 5482-5486
    PubMedGoogle Scholar
  • 51 McCance SG, Menhart N, Castellino FJ. Amino acid residues of the krin-gle-4 and kringle-5 domains of human plasminogen that stabilize their interactions with omega-amino acid ligands. J Biol Chem 1994; 269: 32405-32410
    PubMedGoogle Scholar
  • 52 Hoyer-Hansen G, Ronne E, Solberg H, Behrendt N, Ploug M, Lund LR. et al Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J Biol Chem 1992; 267: 18224-18229
    PubMedGoogle Scholar
  • 53 Miles LA. Regulation of fibrinolysis and proteolysis by plasminogen receptors. Biol Clin Hematol 1993; 15: 107-115
    PubMedGoogle Scholar
  • 54 Beebe DP, Miles LA, Plow EF. A linear amino acid sequence involved in the interaction of t-PA with its endothelial cell receptor. Blood 1989; 74: 2034-2037
    PubMedGoogle Scholar